Rain Biotech Solutions Successfully Closes Seed Round

SHATIN, Hong Kong, Feb. 1, 2024 -- Rain Biotech Solutions is pleased to announce that we have successfully concluded our seed round raise. RBS is the premier provider for intelligent solutions along the therapeutic and research value chain. Its first-of-it’s-kind AI Cell Sorter pairs with the AI imager and smart bioreactor to drive therapeutic innovation, improve diagnostic precision, and enhance patient care outcomes. RBS is made in Hong Kong, and supported by the Hong Kong government to bring its integrated AI solutions to researchers, academics, and healthcare providers.  Congratulations to the team, and we look forward to seeing more achievements moving forward.